Cargando…

Circulating neuregulin1‐β in heart failure with preserved and reduced left ventricular ejection fraction

AIMS: Neuregulin1‐β (NRG1‐β) is released from microvascular endothelial cells in response to inflammation with compensatory cardioprotective effects. Circulating NRG1‐β is elevated in heart failure (HF) with reduced ejection fraction (HFrEF) but not studied in HF with preserved EF (HFpEF). METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hage, Camilla, Wärdell, Eva, Linde, Cecilia, Donal, Erwan, Lam, Carolyn S.P., Daubert, Claude, Lund, Lars H., Månsson‐Broberg, Agneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160501/ https://www.ncbi.nlm.nih.gov/pubmed/31981321 http://dx.doi.org/10.1002/ehf2.12615

Ejemplares similares

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
por: Löfström, Ulrika, et al.
Publicado: (2019)

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study
por: Hage, Camilla, et al.
Publicado: (2015)

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
por: Lund, Lars H., et al.
Publicado: (2021)

Long‐term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non‐cardiac mortality
por: Shahim, Angiza, et al.
Publicado: (2023)

Predictors of long‐term outcome in heart failure with preserved ejection fraction: a follow‐up from the KaRen study
por: Shahim, Angiza, et al.
Publicado: (2021)

The value of exercise echocardiography in heart failure with preserved ejection fraction
por: Donal, Erwan
Publicado: (2019)

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
por: Erhardsson, Mikael, et al.
Publicado: (2023)

Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction
por: Teramoto, Kanako, et al.
Publicado: (2022)

Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction
por: Chandramouli, Chanchal, et al.
Publicado: (2022)

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
por: Huttin, Olivier, et al.
Publicado: (2021)

Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients
por: Hage, Camilla, et al.
Publicado: (2020)

Characterization of the inflammatory‐metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease
por: Packer, Milton, et al.
Publicado: (2020)

Breakthrough in heart failure with preserved ejection fraction: are we there yet?
por: Lim, Shir Lynn, et al.
Publicado: (2016)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
por: Matan, Dmitri, et al.
Publicado: (2022)

Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
por: Bai, Bo, et al.
Publicado: (2019)

Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF study
por: Venkateshvaran, Ashwin, et al.
Publicado: (2022)

QRS duration and cardiovascular mortality in Asian patients with heart failure and preserved and reduced ejection fraction
por: Yap, Jonathan, et al.
Publicado: (2021)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction
por: Henning, Robert J
Publicado: (2020)

Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction
por: Cho, Jae Hyung
Publicado: (2022)

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
por: Stencel, Jason, et al.
Publicado: (2023)

Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction
por: Das, Sarbashis, et al.
Publicado: (2019)

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
por: Patel, Ravi B., et al.
Publicado: (2021)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
por: Nakagawa, Akito, et al.
Publicado: (2022)

Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M., et al.
Publicado: (2022)

Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis
por: Morris, Daniel Armando, et al.
Publicado: (2017)

Is there a latent left ventricular dysfunction in hypertensive patients with preserved ejection fraction ?
por: Taamallah, Karima, et al.
Publicado: (2021)

Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction
por: Cho, Jae Hyung, et al.
Publicado: (2021)

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
por: Dabiri, Yaghoub, et al.
Publicado: (2018)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Right Ventricular Dimension for Heart Failure With Preserved Ejection Fraction Involving Right Ventricular-Vascular Uncoupling
por: Nakagawa, Akito, et al.
Publicado: (2022)

Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2022)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Cardiac steatosis and left ventricular remodeling in heart failure with reduced and preserved ejection fraction
por: Mahmod, Masliza, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m4qgp7kt0a9917coj6kga5dask